Veracyte Inc (NASDAQ:VCYT) achieved a 14% year-over-year revenue growth, reaching approximately $132 million. The company's core testing business saw an 18% revenue growth, driven by a 26% increase in ...
Veracyte raised its 2025 total revenue guidance to $506 million to $510 million, up from $496 million to $504 million. Testing revenue guidance increased to $484 million to $487 million compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results